A LEADER in the management of type 2 diabetes and cardiorenal disease

Subodh Verma¹, Lawrence A Leiter², David A Latter³, Deepak L Bhatt⁴

Affiliations

¹ Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: vermasu@smh.ca.
² Division of Endocrinology and Metabolism, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada.
³ Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
⁴ Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, Mass.

PMID: 31227180
DOI: 10.1016/j.jtcvs.2019.03.134

Free article

Editorial

A LEADER in the management of type 2 diabetes and cardiorenal disease

Subodh Verma et al. J Thorac Cardiovasc Surg. 2020 Mar.

Free article

. 2020 Mar;159(3):978-984.

doi: 10.1016/j.jtcvs.2019.03.134. Epub 2019 Jun 19.

Authors

Subodh Verma¹, Lawrence A Leiter², David A Latter³, Deepak L Bhatt⁴

Affiliations

¹ Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: vermasu@smh.ca.
² Division of Endocrinology and Metabolism, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada.
³ Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
⁴ Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, Mass.

PMID: 31227180
DOI: 10.1016/j.jtcvs.2019.03.134

No abstract available

PubMed Disclaimer

Comment in

Commentary: Leading the way to better surgical outcomes.
Kehler DS, Arora RC. Kehler DS, et al. J Thorac Cardiovasc Surg. 2020 Mar;159(3):985-986. doi: 10.1016/j.jtcvs.2019.04.080. Epub 2019 May 16. J Thorac Cardiovasc Surg. 2020. PMID: 31202447 No abstract available.

Comment on

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
Verma S, Poulter NR, Bhatt DL, Bain SC, Buse JB, Leiter LA, Nauck MA, Pratley RE, Zinman B, Ørsted DD, Monk Fries T, Rasmussen S, Marso SP. Verma S, et al. Circulation. 2018 Dec 18;138(25):2884-2894. doi: 10.1161/CIRCULATIONAHA.118.034516. Circulation. 2018. PMID: 30566004 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A LEADER in the management of type 2 diabetes and cardiorenal disease

Affiliations

A LEADER in the management of type 2 diabetes and cardiorenal disease

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical